Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Asset disposition
Inv. presentation
Acq. announced
Quarterly results
Auditor change
Appointed director
CC transcript
Director departure
|
|
SEELOS THERAPEUTICS, INC. (APRI)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 07/08/2022 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 02/04/2022 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 02/10/2021 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 01/16/2020 |
SC 13G
| Phoenixus AG reports a 6.9% stake in Seelos Therapeutics, Inc. |
| 04/15/2019 |
SC 13G
| LIGAND PHARMACEUTICALS INC reports a 10% stake in Seelos Therapeutics, Inc. |
| 03/11/2019 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 02/08/2019 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 04/09/2018 |
SC 13G
| INTRACOASTAL CAPITAL, LLC reports a 1.6% stake in Apricus Biosciences, Inc. |
| 03/29/2018 |
SC 13G
| SABBY MANAGEMENT, LLC reports a 7.7% stake in Apricus Biosciences, Inc. |
| 09/20/2017 |
SC 13G
| ARMISTICE CAPITAL, LLC reports a 9.6% stake in Apricus Biosciences, Inc. |
| 06/16/2017 |
SC 13G
| Iroquois Capital Management, LLC reports a 5.2% stake in Apricus Biosciences, Inc. |
| 05/02/2017 |
SC 13G
| INTRACOASTAL CAPITAL, LLC has filed a Schedule 13D for Apricus Biosciences, Inc. |
| 10/07/2016 |
SC 13G
| Frigate Ventures LP reports a 7% stake in Apricus Biosciences, Inc |
| 10/03/2016 |
SC 13G
| KOPIN MITCHELL P reports a 6.4% stake in Apricus Biosciences, Inc. |
| 04/01/2010 |
SC 13G
| APRICUS BIOSCIENCES, INC. reports a 5.6% stake in NexMed, Inc. |
|
|